These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23812893)

  • 1. The association between ß-glucocerebrosidase mutations and parkinsonism.
    Swan M; Saunders-Pullman R
    Curr Neurol Neurosci Rep; 2013 Aug; 13(8):368. PubMed ID: 23812893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.
    DePaolo J; Goker-Alpan O; Samaddar T; Lopez G; Sidransky E
    Mov Disord; 2009 Aug; 24(11):1571-8. PubMed ID: 19425057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the link between glucocerebrosidase mutations and parkinsonism.
    Westbroek W; Gustafson AM; Sidransky E
    Trends Mol Med; 2011 Sep; 17(9):485-93. PubMed ID: 21723784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
    Behl T; Kaur G; Fratila O; Buhas C; Judea-Pusta CT; Negrut N; Bustea C; Bungau S
    Transl Neurodegener; 2021 Jan; 10(1):4. PubMed ID: 33446243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher-Associated Parkinsonism.
    Li Y; Li P; Liang H; Zhao Z; Hashimoto M; Wei J
    Cell Mol Neurobiol; 2015 Aug; 35(6):755-61. PubMed ID: 25820783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GBA mutations and Parkinson's disease].
    Wang DX; Xie JX; Song N
    Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase and parkinsonism: lessons to learn.
    Marković I; Kresojević N; Kostić VS
    J Neurol; 2016 May; 263(5):1033-1044. PubMed ID: 26995357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review.
    Filippi M; Balestrino R; Basaia S; Agosta F
    Mov Disord; 2022 Jul; 37(7):1375-1393. PubMed ID: 35521899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications.
    Balestrino R; Schapira AHV
    Neuroscientist; 2018 Oct; 24(5):540-559. PubMed ID: 29400127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism among Gaucher disease carriers.
    Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
    J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
    Goker-Alpan O; Lopez G; Vithayathil J; Davis J; Hallett M; Sidransky E
    Arch Neurol; 2008 Oct; 65(10):1353-7. PubMed ID: 18852351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocerebrosidase mutations in subjects with parkinsonism.
    Lwin A; Orvisky E; Goker-Alpan O; LaMarca ME; Sidransky E
    Mol Genet Metab; 2004 Jan; 81(1):70-3. PubMed ID: 14728994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocerebrosidase and its relevance to Parkinson disease.
    Do J; McKinney C; Sharma P; Sidransky E
    Mol Neurodegener; 2019 Aug; 14(1):36. PubMed ID: 31464647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The link between the GBA gene and parkinsonism.
    Sidransky E; Lopez G
    Lancet Neurol; 2012 Nov; 11(11):986-98. PubMed ID: 23079555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.
    Goker-Alpan O; Masdeu JC; Kohn PD; Ianni A; Lopez G; Groden C; Chapman MC; Cropp B; Eisenberg DP; Maniwang ED; Davis J; Wiggs E; Sidransky E; Berman KF
    Brain; 2012 Aug; 135(Pt 8):2440-8. PubMed ID: 22843412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.
    Beavan MS; Schapira AH
    Ann Med; 2013 Dec; 45(8):511-21. PubMed ID: 24219755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies.
    Sardi SP; Clarke J; Viel C; Chan M; Tamsett TJ; Treleaven CM; Bu J; Sweet L; Passini MA; Dodge JC; Yu WH; Sidman RL; Cheng SH; Shihabuddin LS
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3537-42. PubMed ID: 23297226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase and Parkinson disease: Recent advances.
    Schapira AH
    Mol Cell Neurosci; 2015 May; 66(Pt A):37-42. PubMed ID: 25802027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.
    Tayebi N; Parisiadou L; Berhe B; Gonzalez AN; Serra-Vinardell J; Tamargo RJ; Maniwang E; Sorrentino Z; Fujiwara H; Grey RJ; Hassan S; Blech-Hermoni YN; Chen C; McGlinchey R; Makariou-Pikis C; Brooks M; Ginns EI; Ory DS; Giasson BI; Sidransky E
    Mol Genet Metab; 2017 Dec; 122(4):198-208. PubMed ID: 29173981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Gaucher Disease Mutations in Parkinson Disease.
    Vilageliu L; Grinberg D
    Curr Protein Pept Sci; 2017; 18(7):758-764. PubMed ID: 26965692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.